Security key
83422E204
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 81,373,612
- Total 13F value
- $458,959,522
- Share change
- +13,375
- Put/Call ratio
- 0%
- SEC-reported price per share
- $5.64
- Number of holders
- 125
- Value change
- -$1,220,007
- Number of buys
- 47
- Number of sells
- 57
- Shares outstanding
- 98,227,953
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
125
Top holders
10
SLDB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83422E204
Recent filing periods:
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 9.6%
13D/G row: Invus Global Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Invus Global Management, LLC leads the comparable SEC ownership view at 9.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership
Top 5
Invus Global Management, LLC
9.6%
Vestal Point Capital, LP
7.5%
Adage Capital Management, L.P.
1.8%
PERCEPTIVE ADVISORS LLC
12%
Bain Capital Life Sciences Invest...
8.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
9.6%
|
$27,216,371
7,415,905 shares
|
+$13,457,391 | 31 Mar 2025 |
| Vestal Point Capital, LP |
13D/G
13F
Company
|
7.5%
|
$32,796,600
5,815,000 shares
|
+$22,906,533 | 31 Dec 2025 |
| Adage Capital Management, L.P. |
3/4/5
13D/G
10%+ Owner
|
1.8%
from 13D/G
|
$32,115,515
4,248,084 shares
|
— | 18 Feb 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
12%
|
$73,012,936
11,833,539 shares
|
— | 30 Sep 2025 |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
Company · 10%+ Owner
|
8.1%
|
$48,814,998
7,911,669 shares
|
— | 30 Sep 2025 |
| Siren, L.L.C. |
13F
Individual
|
7.5%
|
$45,756,134
7,415,905 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
125
Shares
81,373,612
Rows available
125
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
122
Q4 2025 holders
125
Holder diff
3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend